Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor site maintenance update without changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:08.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now includes a Locations section with Michigan, Ohio, and Wisconsin sites and removes the HHS Vulnerability Disclosure entry from the footer.
    Difference
    0.4%
    Check dated 2025-12-23T21:37:11.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.2.0 to v3.3.2, a change to metadata rather than study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Removed the site-wide banner about funding lapses and NIH operating status, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:52.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Minor non-substantive updates were detected, such as a revised last-updated timestamp and small formatting changes; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:05:15.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Major update to version 3.2.0 and removal of a specific disease resource; plus a government-operating status notice added.
    Difference
    3%
    Check dated 2025-10-06T05:35:21.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.